Weiss Multi-Strategy Advisers’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-12,000
Closed -$1.36M 601
2015
Q4
$1.36M Buy
12,000
+5,950
+98% +$655K 0.09% 210
2015
Q3
$712K Buy
+6,050
New +$790K 0.03% 290
2014
Q4
Sell
-15,000
Closed -$367K 644
2014
Q3
$367K Sell
15,000
-60,000
-80% -$1.22M 0.01% 460
2014
Q2
$1.33M Buy
75,000
+4,070
+6% +$65.5K 0.03% 385
2014
Q1
$1.42M Buy
70,930
+10,930
+18% +$212K 0.03% 413
2013
Q4
$1.01M Sell
60,000
-20,000
-25% -$277K 0.02% 433
2013
Q3
$850K Buy
+80,000
New +$700K 0.02% 437

Other funds holding ANAC

Weiss Multi-Strategy Advisers's ANAC Position: Q1 2016 in Review

Weiss Multi-Strategy Advisers sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 12,000 shares — an estimated $1.36M sold.

Weiss Multi-Strategy Advisers first reported a position in ANAC in Q3 2013 and held it in 7 quarters. The position peaked at $1.42M in Q1 2014. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • Weiss Multi-Strategy Advisers reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 12,000 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $1.36M.
  • Weiss Multi-Strategy Advisers first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 7 quarters.
  • Weiss Multi-Strategy Advisers's ANACOR PHARMACEUTICALS INC COM position peaked at $1.42M in Q1 2014.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2016, filed 16 May 2016.